Stock analysts at started coverage on shares of OrthoPediatrics Corp. (NASDAQ:KIDS) in a note issued to investors on Monday, November 6th, Marketbeat Ratings reports. The firm set a “buy” rating and a $24.00 price target on the stock. ‘s price target points to a potential upside of 25.13% from the stock’s current price.
Separately, Piper Jaffray Companies started coverage on OrthoPediatrics Corp. in a research note on Monday, November 6th. They issued an “overweight” rating and a $24.00 price target for the company.
OrthoPediatrics Corp. (NASDAQ:KIDS) opened at $19.18 on Monday. OrthoPediatrics Corp. has a twelve month low of $17.03 and a twelve month high of $23.00.
In related news, Director Harold Ruf bought 11,500 shares of the firm’s stock in a transaction on Monday, October 16th. The stock was purchased at an average price of $13.00 per share, with a total value of $149,500.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
About OrthoPediatrics Corp.
OrthoPediatrics Corp. is a United States-based medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.
Receive News & Ratings for OrthoPediatrics Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics Corp. and related companies with MarketBeat.com's FREE daily email newsletter.